中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Lexaria Bioscience Corp. (LEXX) Current Reports & Earnings Releases

View full earnings calendar →

FiledFormItemsFiling
2026-08-17 8-K Other Events SEC
2026-08-10 8-K Listing Notice SEC
2026-07-30 8-K Item 3.03, Charter Amendments, Financial Statements & Exhibits SEC
2026-02-06 8-K Listing Notice SEC
2026-01-28 8-K Shareholder Vote Results SEC
2025-12-16 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-09-29 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-09-25 8-K Termination of Agreement SEC
2025-06-12 8-K Material Agreement SEC
2025-04-28 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2025-02-05 8-K Material Agreement, Financial Statements & Exhibits SEC
2025-01-15 8-K Shareholder Vote Results SEC
2025-01-03 8-K Officer / Director Changes SEC
2024-12-18 8-K Material Agreement SEC
2024-10-18 8-K Item 5.08 SEC
2024-10-16 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2024-10-02 8-K Officer / Director Changes SEC
2024-09-05 8-K Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits SEC
2024-08-22 8-K Material Agreement, Financial Statements & Exhibits SEC
2024-07-17 8-K Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits SEC
2024-04-30 8-K Material Agreement, Unregistered Sales, Financial Statements & Exhibits SEC
2024-04-24 8-K Shareholder Vote Results SEC
2024-03-21 8-K Material Agreement SEC
2024-03-15 8-K Officer / Director Changes SEC
2024-03-01 8-K Other Events SEC
2024-02-16 8-K Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2024-01-30 8-K Other Events SEC
2024-01-24 8-K Reg FD Disclosure, Financial Statements & Exhibits SEC
2024-01-04 8-K Reg FD Disclosure, Financial Statements & Exhibits SEC

Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.